FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Dawes

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Ying Chen; Peter T Dawes; Derek L Mattey
Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking.
Ying Chen; Peter T Dawes; Jon C Packham; Derek L Mattey
Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study.
John R Glossop; Peter T Dawes; Derek Mattey
Antinuclear antibodies are associated with tumor necrosis factor receptor I gene polymorphism in patients with rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Dawes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ying Chen; Peter T Dawes; Derek L Mattey
Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking.
Cytokine 2012;58(3):390-7.
2012: Ying Chen; Peter T Dawes; Jon C Packham; Derek L Mattey
Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study.
Arthritis research & therapy 2012;14(2):R81.
2011: John R Glossop; Peter T Dawes; Derek Mattey
Antinuclear antibodies are associated with tumor necrosis factor receptor I gene polymorphism in patients with rheumatoid arthritis.
Clinical and experimental rheumatology 2011;29(4):609-15.
2011: Ying Chen; Peter T Dawes; Jonathan C Packham; Derek L Mattey
Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis.
The Journal of rheumatology 2011;38(5):802-9.
2010: Derek Mattey; Peter T Dawes; Andrew B Hassell; Ann Brownfield; Jonathan C Packham
Effect of psychological distress on continuation of anti-tumor necrosis factor therapy in patients with rheumatoid arthritis.
The Journal of rheumatology 2010;37(10):2021-4.
2009: Derek Mattey; Ann Brownfield; Peter T Dawes
Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis.
The Journal of rheumatology 2009;36(6):1180-7.
2007: Derek Mattey; John R Glossop; Nicola B Nixon; Peter T Dawes
Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis.
Arthritis and rheumatism 2007;56(12):3940-8.
2007: Mark Harrison; Andrew B Hassell; Peter T Dawes; David Scott; SM Knight; M J Davis; Diarmuid Mulherin; Deborah Symmons
The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice.
Rheumatology (Oxford, England) 2007;46(5):849-55.
2006: John R Glossop; Peter T Dawes; Derek Mattey
Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis.
Rheumatology (Oxford, England) 2006;45(10):1223-9.
2006: A V Pace; C M Dowson; Peter T Dawes
Self-referral of symptoms (SOS) follow-up system of appointments for patients with uncertain diagnoses in rheumatology out-patients.
Rheumatology (Oxford, England) 2006;45(2):201-3.
2005: John R Glossop; Peter T Dawes; Andrew B Hassell; Derek Mattey
Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
The Journal of rheumatology 2005;32(9):1673-8.
2005: Derek Mattey; Nicola B Nixon; Peter T Dawes; J Kerr
Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(8):1190-4.
2005: Kirstie L Haywood; Andrew M Garratt; Peter T Dawes
Patient-assessed health in ankylosing spondylitis: a structured review.
Rheumatology (Oxford, England) 2005;44(5):577-86.
2005: John R Glossop; Peter T Dawes; Nicola B Nixon; Derek Mattey
Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Arthritis research & therapy 2005;7(6):R1227-34.
2004: Kelvin Jordan; Kirstie L Haywood; Krysia Dziedzic; Andrew M Garratt; Peter W Jones; Bie Nio Ong; Peter T Dawes
Assessment of the 3-dimensional Fastrak measurement system in measuring range of motion in ankylosing spondylitis.
The Journal of rheumatology 2004;31(11):2207-15.
2004: Preeti Shah; Sian M Griffith; Mike Shadforth; June Fisher; Peter T Dawes; Kay V Poulton; Wendy Thomson; W E R Ollier; Derek Mattey
Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
The Journal of rheumatology 2004;31(10):1903-5.
2004: Kirstie L Haywood; Andrew M Garratt; Kelvin Jordan; Krysia Dziedzic; Peter T Dawes
Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness.
Rheumatology (Oxford, England) 2004;43(6):750-7.
2004: Derek Mattey; Peter T Dawes; Nicola B Nixon; L Goh; MJ Banks; George D Kitas
Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease.
Annals of the rheumatic diseases 2004;63(4):420-5.
2004: Derek Mattey; Nicola B Nixon; Peter T Dawes; W E R Ollier; Al Hajeer
Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis.
Genes and immunity 2004;5(2):147-9.
2003: John R Glossop; Nicola B Nixon; Peter T Dawes; Andrew B Hassell; Derek Mattey
No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis.
The Journal of rheumatology 2003;30(7):1406-9.
2003: Kirstie L Haywood; Andrew M Garratt; Krysia Dziedzic; Peter T Dawes
Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index.
The Journal of rheumatology 2003;30(4):764-73.
2003: L J Badcock; S Clarke; P W Jones; Peter T Dawes; Derek Mattey
Abnormal IgA levels in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(1):83-4.
2002: Kirstie L Haywood; Andrew M Garratt; Krysia Dziedzic; Peter T Dawes
Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness.
Rheumatology (Oxford, England) 2002;41(12):1380-7.
2002: Kirstie L Haywood; A M Garratt; Kelvin Jordan; Krysia Dziedzic; Peter T Dawes
Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness.
Rheumatology (Oxford, England) 2002;41(11):1295-302.
2002: Derek Mattey; Peter T Dawes; June Fisher; Ann Brownfield; Wendy Thomson; Ali H Hajeer; W E R Ollier
Nodular disease in rheumatoid arthritis: association with cigarette smoking and HLA-DRB1/TNF gene interaction.
The Journal of rheumatology 2002;29(11):2313-8.
2002: Derek Mattey; Peter T Dawes; Sheila Clarke; June Fisher; Ann Brownfield; Wendy Thomson; Ali H Hajeer; W E R Ollier
Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis.
Arthritis and rheumatism 2002;47(4):403-7.
2002: Derek Mattey; David Hutchinson; Peter T Dawes; Nicola B Nixon; Sheila Clarke; June Fisher; Ann Brownfield; Julie Alldersea; Anthony A Fryer; Richard C Strange
Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus.
Arthritis and rheumatism 2002;46(3):640-6.
2002: A H Johnson; Andrew B Hassell; Peter W Jones; Derek Mattey; J Saklatvala; Peter T Dawes
The mechanical joint score: a new clinical index of joint damage in rheumatoid arthritis.
Rheumatology (Oxford, England) 2002;41(2):189-95.
2001: K Jordan; Krysia Dziedzic; Ricky Mullis; Peter T Dawes; P W Jones
The development of three-dimensional range of motion measurement systems for clinical practice.
Rheumatology (Oxford, England) 2001;40(10):1081-4.
2001: Derek Mattey; Andrew B Hassell; Peter T Dawes; NT Cheung; Kay V Poulton; Wendy Thomson; Ali H Hajeer; W E R Ollier
Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis.
Arthritis and rheumatism 2001;44(7):1529-33.
2001: J C Chehata; Andrew B Hassell; S A Clarke; Derek Mattey; M A Jones; Peter W Jones; Peter T Dawes
Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity.
Rheumatology (Oxford, England) 2001;40(4):447-52.
2001: Derek Mattey; Peter T Dawes; M A Gonzalez-Gay; C Garcia-Porrua; Wendy Thomson; Ali H Hajeer; W E R Ollier
HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
The Journal of rheumatology 2001;28(2):232-9.
2000: Derek Mattey; Peter T Dawes; NT Cheung
Serum matrix metalloproteinase 3 as a predictor of joint destruction in rheumatoid arthritis: comment on the article by Yamanaka et al.
Arthritis and rheumatism 2000;43(11):2614-5.
2000: S M Griffith; J Fisher; S Clarke; B Montgomery; Peter W Jones; J Saklatvala; Peter T Dawes; Mike Shadforth; T E Hothersall; Andrew B Hassell; Elaine M Hay
Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?
Rheumatology (Oxford, England) 2000;39(10):1102-9.
2000: E Evans; Peter T Dawes; Derek Mattey
An unusual case of adult varicella-associated arthritis.
Rheumatology (Oxford, England) 2000;39(7):806-8.
2000: Kelvin Jordan; Krysia Dziedzic; Peter W Jones; Bie Nio Ong; Peter T Dawes
The reliability of the three-dimensional FASTRAK measurement system in measuring cervical spine and shoulder range of motion in healthy subjects.
Rheumatology (Oxford, England) 2000;39(4):382-8.
2000: NT Cheung; Peter T Dawes; Kay V Poulton; W E R Ollier; D J Taylor; Derek Mattey
High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis.
The Journal of rheumatology 2000;27(4):882-7.
2000: Derek Mattey; Andrew B Hassell; Peter T Dawes; Peter W Jones; L Yengi; Julie Alldersea; Richard C Strange; Anthony A Fryer
Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes.
Arthritis and rheumatism 2000;43(4):859-64.
2000: Fraser Birrell; Andrew B Hassell; P W Jones; Peter T Dawes
How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study.
Clinical rheumatology 2000;19(3):195-9.
2000: AM Salih; Nicola B Nixon; Peter T Dawes; Derek Mattey
Antibodies to neuroblastoma cells in rheumatoid arthritis: a potential marker for neuropathy.
Clinical and experimental rheumatology 2000;18(1):23-30.
1999: Derek Mattey; Andrew B Hassell; Peter T Dawes; W E R Ollier; Al Hajeer
Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: influence on disease outcome.
Arthritis and rheumatism 1999;42(12):2698-704.
1999: Derek Mattey; Andrew B Hassell; MJ Plant; NT Cheung; Peter T Dawes; Peter W Jones; Wendy Thomson; Kay V Poulton; Ali H Hajeer; W E R Ollier
The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(12):1221-7.
1999: Derek Mattey; Peter T Dawes; NT Cheung
Circulating levels of matrix metalloproteinases in rheumatic diseases.
The Journal of rheumatology 1999;26(10):2281-2.
1999: Peter T Dawes
Stoke Ankylosing Spondylitis Spine Score.
The Journal of rheumatology 1999;26(4):993-6.
1999: Derek Mattey; A B Hassell; MJ Plant; Peter T Dawes; W R Ollier; Peter W Jones; Anthony A Fryer; Julie Alldersea; R C Strange
Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope.
Annals of the rheumatic diseases 1999;58(3):164-8.
1999: AM Salih; Nicola B Nixon; Peter T Dawes; Derek Mattey
Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy.
The Journal of rheumatology 1999;26(3):551-5.
1999: LJ Scott; GI Russell; Nicola B Nixon; Peter T Dawes; Derek Mattey
Oxidation of alpha1-proteinase inhibitor by the myeloperoxidase-hydrogen peroxidase system promotes binding to immunoglobulin A.
Biochemical and biophysical research communications 1999;255(3):562-7.
1999: MA Layton; Peter W Jones; Julie Alldersea; Richard C Strange; Anthony A Fryer; Peter T Dawes; Derek Mattey
The therapeutic response to D-penicillamine in rheumatoid arthritis: influence of glutathione S-transferase polymorphisms.
Rheumatology (Oxford, England) 1999;38(1):43-7.
1998: AM Salih; Nicola B Nixon; Peter T Dawes; Derek Mattey
Prevalence of antibodies to neurofilament polypeptides in patients with rheumatoid arthritis complicated by peripheral neuropathy.
Clinical and experimental rheumatology 1998;16(6):689-94.
1998: Fraser Birrell; Andrew B Hassell; P W Jones; Peter T Dawes
Why not use OSRA? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RA.
The Journal of rheumatology 1998;25(9):1709-15.
1998: MA Layton; Krysia Dziedzic; Peter T Dawes
Sacroiliitis in an HLA B27-negative patient following giardiasis.
British journal of rheumatology 1998;37(5):581-3.
1998: LJ Scott; E L Evans; Peter T Dawes; GI Russell; Derek Mattey
Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se.
British journal of rheumatology 1998;37(4):398-404.
1998: MJ Plant; Peter W Jones; J Saklatvala; W E R Ollier; Peter T Dawes
Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study.
The Journal of rheumatology 1998;25(3):417-26.
1998: MA Layton; C Musgrove; Peter T Dawes
Polyarthritis, rash and lymphadenopathy: case reports of two patients with angioimmunoblastic lymphadenopathy presenting to a rheumatology clinic.
Clinical rheumatology 1998;17(2):148-51.
1997: MJ Plant; A A Borg; Krysia Dziedzic; J Saklatvala; Peter T Dawes
Radiographic patterns and response to corticosteroid hip injection.
Annals of the rheumatic diseases 1997;56(8):476-80.
1997: Derek Mattey; Nicola B Nixon; Peter T Dawes; LJ Scott; GI Russell
Measurement of IgA-alpha 1-antitrypsin complex in rheumatoid arthritis: a question of specificity?
Annals of the rheumatic diseases 1997;56(7):439-40.
1997: Derek Mattey; Peter T Dawes; Nicola B Nixon; H Slater
Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor.
Annals of the rheumatic diseases 1997;56(7):426-31.
1997: L J Scott; Peter T Dawes; Derek Mattey
Comparison of IgA-alpha 1-antitrypsin levels in rheumatoid and reactive arthritis.
Biochemical Society transactions 1997;25(2):370S.
1997: E H Carpenter; MJ Plant; Andrew B Hassell; Mike Shadforth; J Fisher; S Clarke; T E Hothersall; Peter T Dawes
Management of oral complications of disease-modifying drugs in rheumatoid arthritis.
British journal of rheumatology 1997;36(4):473-8.
1997: Derek Mattey; LJ Scott; Peter T Dawes; Nicola B Nixon
Recognition of complement factor H by a monoclonal antibody used for "specifically" measuring IgA-alpha 1 antitrypsin complexes.
Clinical and experimental rheumatology 1997;15(1):117-8.
1996: A M Salih; Nicola B Nixon; R M Gagan; P Heath; C P Hawkins; Peter T Dawes; Derek Mattey
Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy.
British journal of rheumatology 1996;35(8):725-31.
1996: NT Cheung; Derek Mattey; Peter T Dawes; D J Taylor
Serum pro-matrix metalloproteinase 3 in rheumatoid arthritis: a reflection of local or systemic inflammation?
Arthritis and rheumatism 1996;39(5):884-6.
1996: H L Averns; J Oxtoby; H G Taylor; Peter W Jones; K Dziedzic; Peter T Dawes
Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS).
British journal of rheumatology 1996;35(4):373-6.
1996: H L Averns; J Oxtoby; H G Taylor; Peter W Jones; K Dziedzic; Peter T Dawes
Smoking and outcome in ankylosing spondylitis.
Scandinavian journal of rheumatology 1996;25(3):138-42.
1995: H L Averns; N T Cheung; Peter T Dawes
Painful knees associated with a septic focus.
British journal of rheumatology 1995;34(9):862-4.
1995: Peter T Dawes; P D Fowler
Treatment of early rheumatoid arthritis: a review of current and future concepts and therapy.
Clinical and experimental rheumatology 1995;13(3):381-94.
1995: N T Cheung; J Saklatvala; Peter T Dawes
Multiple joint avascular necrosis: beware of tuberculosis and human immunodeficiency virus--a rare but important cause.
British journal of rheumatology 1995;34(4):387-91.
1995: Andrew B Hassell; MJ Plant; S Clarke; J Fisher; Peter W Jones; J Saklatvala; P D Fowler; M F Shadforth; Peter T Dawes
Small joint synovitis in rheumatoid arthritis: should it be assessed separately?
British journal of rheumatology 1995;34(1):51-5.
1994: MJ Plant; J Saklatvala; A A Borg; Peter W Jones; Peter T Dawes
Measurement and prediction of radiological progression in early rheumatoid arthritis.
The Journal of rheumatology 1994;21(10):1808-13.
1994: Andrew B Hassell; P D Fowler; Peter T Dawes
Intra-bursal tetracycline in the treatment of olecranon bursitis in patients with rheumatoid arthritis.
British journal of rheumatology 1994;33(9):859-60.
1994: A A Borg; M J Davis; Peter T Dawes; M F Shadforth
Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.
Clinical rheumatology 1994;13(3):522-4.
1994: MJ Plant; J Saklatvala; Peter W Jones; Peter T Dawes
Prediction of radiographic damage in hands and feet in rheumatoid arthritis by clinical evaluation.
Clinical rheumatology 1994;13(3):487-91.
1994: Andrew B Hassell; MJ Plant; Peter T Dawes
Focal myositis: another cause of pseudothrombophlebitis.
British journal of rheumatology 1994;33(7):687.
1994: A A Borg; Nicola B Nixon; Peter T Dawes; Derek Mattey
Increased IgA antibodies to cytokeratins in the spondyloarthropathies.
Annals of the rheumatic diseases 1994;53(6):391-5.
1994: Derek Mattey; E Evans; Peter T Dawes
The effects of Tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro.
Annals of the rheumatic diseases 1994;53(4):250-5.
1994: A A Borg; Peter T Dawes; C H Swan; T E Hothersall
Persistent monoarthritis and occult coeliac disease.
Postgraduate medical journal 1994;70(819):51-3.
1993: A A Borg; Peter T Dawes; Derek Mattey
Autoantibodies to nuclear lamins and to intermediate filament proteins.
The Journal of rheumatology 1993;20(11):1988-90.
1993: A A Borg; P D Fowler; M F Shadforth; Peter T Dawes
Use of the Stoke Index to differentiate between disease-modifying agents and non-steroidal anti-inflammatory drugs in rheumatoid arthritis.
Clinical and experimental rheumatology 1993;11(5):469-72.
1993: Andrew B Hassell; M J Davis; P D Fowler; S Clarke; J Fisher; M F Shadforth; Peter W Jones; Peter T Dawes
The relationship between serial measures of disease activity and outcome in rheumatoid arthritis.
The Quarterly journal of medicine 1993;86(9):601-7.
1993: Derek Mattey; Nicola B Nixon; C Wynn-Jones; Peter T Dawes
Demonstration of cytokeratin in endothelial cells of the synovial microvasculature in situ and in vitro.
British journal of rheumatology 1993;32(8):676-82.
1993: H G Taylor; Nicola B Nixon; Peter T Dawes
Interleukin-2 production in early rheumatoid arthritis.
Clinical rheumatology 1993;12(2):285-6.
1993: A A Borg; C Wynn-Jones; Peter T Dawes
Synovial sarcoma manifesting as a single joint flare in rheumatoid arthritis.
Clinical rheumatology 1993;12(1):89-92.
1993: A A Borg; Peter T Dawes; Derek Mattey
Increased levels of IgA antibodies to cytokeratin-18 and epidermal keratin in rheumatoid arthritis.
Arthritis and rheumatism 1993;36(2):229-33.
1993: A A Borg; M J Davis; P D Fowler; M F Shadforth; Peter T Dawes
Rifampicin in early rheumatoid arthritis.
Scandinavian journal of rheumatology 1993;22(1):39-42.
1993: H G Taylor; Nicola B Nixon; Peter T Dawes
Natural killer cell cytotoxicity and alpha-interferon in early rheumatoid arthritis.
Scandinavian journal of rheumatology 1993;22(6):280-3.
1992: A A Borg; J Gray; Peter T Dawes
Yersinia-related arthritis in the United Kingdom. A report of 12 cases and review of the literature.
The Quarterly journal of medicine 1992;84(304):575-82.
1991: M J Davis; Peter T Dawes; P D Fowler; S Clarke; J Fisher; M F Shadforth
Should disease-modifying agents be used in mild rheumatoid arthritis?
British journal of rheumatology 1991;30(6):451-4.
1991: H G Taylor; T Wardle; E J Beswick; Peter T Dawes
The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis.
British journal of rheumatology 1991;30(5):330-5.
1991: H G Taylor; P D Fowler; M J David; Peter T Dawes
Intra-articular steroids: confounder of clinical trials.
Clinical rheumatology 1991;10(1):38-42.
1991: H G Taylor; E J Beswick; Peter T Dawes
Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.
Clinical rheumatology 1991;10(1):43-8.
1991: M J Davis; Peter T Dawes; P D Fowler; M F Shadforth; I Lewin; D R Stanworth
The association and predictive value of the complex immunoglobulin A-alpha 1-antitrypsin in the development of erosions in early rheumatoid arthritis.
Scandinavian journal of rheumatology 1991;20(1):23-7.
1991: H G Taylor; R Gadd; E J Beswick; M Venkateswaran; Peter T Dawes
Quantitative radio-isotope scanning in ankylosing spondylitis: a clinical, laboratory and computerised tomographic study.
Scandinavian journal of rheumatology 1991;20(4):274-9.
1990: Peter T Dawes; M F Shadforth; T E Hothersall; B McGuinness
Primary care--the educational need.
British journal of rheumatology 1990;29(5):401.
1990: M J Davis; Peter T Dawes; P D Fowler; T P Sheeran; M F Shadforth; Fouad M Ziade; M Collins; P Jones
Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis.
British journal of rheumatology 1990;29(2):111-5.
1989: M J Davis; Peter T Dawes; E Beswick; I V Lewin; D R Stanworth
Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin.
British journal of rheumatology 1989;28(5):410-3.
1989: H G Taylor; Nicola B Nixon; T P Sheeran; Peter T Dawes
Rheumatoid arthritis and chronic lymphatic leukaemia.
Clinical and experimental rheumatology 1989;7(5):529-32.
1989: David Scott; Peter T Dawes; E Tunn; P D Fowler; M F Shadforth; J Fisher; S Clarke; M Collins; P Jones; A J Popert
Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study.
British journal of rheumatology 1989;28(2):128-33.
1988: T P Sheeran; F R Jackson; Peter T Dawes; M Collins; M F Shadforth
Measurement of natural killer cell cytotoxicity by area under a cytotoxic curve. A method suitable for rheumatoid arthritis.
Journal of immunological methods 1988;115(1):95-8.
1988: Peter T Dawes; T P Sheeran; T E Hothersall
Chest pain--a common feature of ankylosing spondylitis.
Postgraduate medical journal 1988;64(747):27-9.
1987: Peter T Dawes; R Jackson; M F Shadforth; I V Lewin; D R Stanworth
The relationship between the complex of immunoglobulin A and alpha-1-antitrypsin, its constituent components and the acute-phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or D-penicillamine.
British journal of rheumatology 1987;26(5):351-3.
1987: Peter T Dawes; T P Sheeran; E J Beswick; T E Hothersall
Enthesopathy index in ankylosing spondylitis.
Annals of the rheumatic diseases 1987;46(9):717.
1987: P D Fowler; Peter T Dawes; T P Sheeran; M F Shadforth
Combination therapy in rheumatoid arthritis--study design.
British journal of rheumatology 1987;26(4):314-5.
1987: Peter T Dawes; T P Sheeran; P D Fowler; M F Shadforth
Improving the response to gold or D-penicillamine by addition of sulphasalazine. A pilot study in 25 patients with rheumatoid arthritis.
Clinical and experimental rheumatology 1987;5(2):151-3.
1986: David Scott; Peter T Dawes; P D Fowler; M F Shadforth
Calculating radiological progression in rheumatoid arthritis.
Clinical rheumatology 1986;5(4):445-9.
1986: Peter T Dawes; P D Fowler; R Jackson; M Collins; M F Shadforth; R Stone; David Scott
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy.
Annals of the rheumatic diseases 1986;45(11):945-9.
1986: Peter T Dawes; P D Fowler; S Clarke; J Fisher; A Lawton; M F Shadforth
Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression.
British journal of rheumatology 1986;25(1):44-9.
1986: P D Fowler; Peter T Dawes; V A John; P A Shotton
Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation.
European journal of clinical pharmacology 1986;31(4):469-72.
1985: David Scott; Peter T Dawes; P D Fowler; K A Grindulis; M Shadforth; P A Bacon
Anti-rheumatic drugs and joint damage in rheumatoid arthritis.
The Quarterly journal of medicine 1985;54(213):49-59.
1984: Peter T Dawes; P D Fowler; M F Shadforth; T E Hothersall
Availability of non-steroidal anti-inflammatory drugs over the counter: information needed.
British medical journal (Clinical research ed.) 1984;289(6442):413-4.